Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Capital Expenditures: 2009-2024

Historic Capital Expenditures for Assembly Biosciences (ASMB) over the last 15 years, with Dec 2024 value amounting to $28,000.

  • Assembly Biosciences' Capital Expenditures was N/A to $42,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $141,000, marking a year-over-year change of. This contributed to the annual value of $28,000 for FY2024, which is 89.02% down from last year.
  • As of FY2024, Assembly Biosciences' Capital Expenditures stood at $28,000, which was down 89.02% from $255,000 recorded in FY2023.
  • Assembly Biosciences' 5-year Capital Expenditures high stood at $3.1 million for FY2021, and its period low was $28,000 during FY2024.
  • Its 3-year average for Capital Expenditures is $128,333, with a median of $102,000 in 2022.
  • As far as peak fluctuations go, Assembly Biosciences' Capital Expenditures surged by 558.72% in 2021, and later plummeted by 96.71% in 2022.
  • Yearly analysis of 5 years shows Assembly Biosciences' Capital Expenditures stood at $470,000 in 2020, then surged by 558.72% to $3.1 million in 2021, then slumped by 96.71% to $102,000 in 2022, then skyrocketed by 150.00% to $255,000 in 2023, then crashed by 89.02% to $28,000 in 2024.